Cardiol Therapeutics (CRDL) Change in Cash (2020 - 2026)
Cardiol Therapeutics (CRDL) posted Change in Cash of $4.4 million for Q1 2026, down 40.53% on a QoQ basis from $7.4 million in Q4 2025, and up 187.95% year-over-year from $1.5 million in Q1 2025.
Cardiol Therapeutics (CRDL) Change in Cash (2020 - 2026) Analysis & Trends
Cardiol Therapeutics' Change in Cash history runs 7 years deep, the most recent figure standing at $4.4 million for Q1 2026.
- Quarterly Change in Cash rose 187.95% year-over-year to $4.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 million (up 172.93% YoY) and the FY2025 annual result came in at -$6.0 million, down 33.83% from the prior year.
- Change in Cash was $4.4 million for Q1 2026 at Cardiol Therapeutics, down from $7.4 million in the prior quarter.
- Across five years, Change in Cash topped out at $9.4 million in Q4 2024 and bottomed at -$9.3 million in Q4 2022.
- A 5-year average of -$2.7 million and a median of -$4.0 million in 2023 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2022 — Change in Cash tumbled 362.27% — and 2024, when it soared 296.6%.
- Cardiol Therapeutics' Change in Cash stood at -$9.3 million in 2022, then surged by 48.68% to -$4.8 million in 2023, then surged by 296.6% to $9.4 million in 2024, then decreased by 21.04% to $7.4 million in 2025, then tumbled by 40.53% to $4.4 million in 2026.
- Business Quant data shows CRDL's Change in Cash at $4.4 million in Q1 2026, $7.4 million in Q4 2025, and -$5.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Cardiol Therapeutics | 134.05 Mn | 134.05 Mn | - | 4.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.40 Mn |
| Dec 31, 2025 | 7.40 Mn |
| Sep 30, 2025 | -5.04 Mn |
| Jun 30, 2025 | -3.27 Mn |
| Mar 31, 2025 | -5.00 Mn |
| Dec 31, 2024 | 9.37 Mn |
| Sep 30, 2024 | -5.70 Mn |
| Jun 30, 2024 | -3.44 Mn |
| Mar 31, 2024 | -5.08 Mn |
| Dec 31, 2023 | -4.77 Mn |
| Sep 30, 2023 | -2.56 Mn |
| Jun 30, 2023 | -4.00 Mn |
| Mar 31, 2023 | -7.40 Mn |
| Dec 31, 2022 | -9.29 Mn |
| Sep 30, 2022 | -1.32 Mn |
| Jun 30, 2022 | -2.03 Mn |
| Mar 31, 2022 | -8.24 Mn |
| Dec 31, 2021 | 43.84 Mn |
| Sep 30, 2021 | -3.23 Mn |
| Jun 30, 2021 | 11.97 Mn |